Skip to main content

Table 2 Differential Metabolites derived from OPLS-DA model of 1H NMR analysis between gastric cancer patients and normal controls

From: Tissue metabolic profiling of human gastric cancer assessed by 1H NMR

Metabolites

Chemical shift

Mutiplicitya

Gastric cancer vs Normal control

(ppm)

VIPb

FCc

P Valued

Adjust p value

FDR

1 VLDL: CH 3-(CH2) n-

0.892

br

1.15

−1.31

0.015

0.003

0.020

2 Isoleucine

0.942

t

2.35

1.12

0.000

0.000

0.000

 

1.014

d

3.05

1.37

0.000

0.000

0.000

3 Leucine

0.96

t

2.28

1.02

0.000

0.000

0.000

4 Valine

0.99

d

2.81

1.12

0.000

0.000

0.000

 

1.01

d

2.81

1.10

0.000

0.000

0.000

5 β-hydroxybutyrate

1.2

d

1.03

−1.31

0.002

0.007

0.003

 

4.16

d

2.27

−1.02

0.000

0.000

0.000

6 Lactate

1.33

d

3.62

1.22

0.000

0.000

0.000

 

4.11

q

2.14

1.16

0.000

0.000

0.000

7 2-Hydroxyisobutyric acid

1.44

s

1.26

−1.02

0.000

0.000

0.000

8 Citrulline

1.57

m

2.51

−2.25

0.000

0.000

0.000

9 VLDL: −CH 2-CH2-CH2O

1.58

br

2.64

−1.76

0.000

0.000

0.000

10 Acetate

1.93

s

2.24

−1.19

0.000

0.000

0.000

11 N-Acetyl glycoprotein

2.05

s

1.81

1.14

0.000

0.000

0.000

12 O-Acetyl glycoprotein

2.07

s

3.32

2.10

0.000

0.000

0.000

13 D-ribose

2.23

s

1.84

−1.56

0.000

0.000

0.000

14 Acetone

2.23

s

1.84

−1.56

0.000

0.000

0.000

15 Lipid,-CH 2-C = O

2.26

br

1.87

−1.18

0.000

0.000

0.000

16 Acetoacetate

2.28

s

1.34

−1.16

0.019

0.013

0.027

17 Acetoacetic acid

2.31

s

1.50

−1.30

0.000

0.000

0.000

18 Glutamate

2.356

m

2.65

1.29

0.000

0.000

0.000

 

3.768

m

2.52

1.18

0.000

0.000

0.000

19 Succinate

2.41

s

2.66

1.01

0.000

0.000

0.000

20 Glutamine

2.45

m

2.24

1.02

0.000

0.000

0.000

21 Glutathione

2.56

m

2.41

1.51

0.000

0.000

0.000

 

2.96

m

2.28

1.45

0.000

0.000

0.000

22 Methylamine

2.59

s

2.03

2.26

0.000

0.000

0.000

23 Aspartate

2.68

dd

1.38

1.54

0.000

0.000

0.000

 

2.82

dd

1.62

1.56

0.000

0.000

0.000

24 Dimethylamine

2.732

s

1.43

1.02

0.040

0.045

0.045

25 Acetic acid

3.00

s

1.99

−1.09

0.000

0.000

0.119

26 Phosphocreatine

3.04

s

1.95

−1.08

0.000

0.000

0.000

 

3.93

s

1.12

−1.08

0.000

0.000

0.000

27 Creatine

3.04

s

1.95

−1.08

0.000

0.000

0.000

 

3.94

s

1.12

−1.08

0.000

0.000

0.000

28 Ceatinine

3.04

s

1.95

−1.08

0.000

0.000

0.000

 

3.448

s

1.03

−1.00

0.004

0.017

0.007

29 Choline

3.2

s

1.33

−1.34

0.000

0.011

0.000

30 PC (phosphochline)

3.21

s

1.78

−1.38

0.000

0.000

0.000

31 Trimethylamine-N-oxide (TMAO)

3.27

s

1.67

1.71

0.000

0.000

0.000

32 myo-Inositol

3.54

dd

2.69

−1.68

0.000

0.000

0.000

 

3.63

t

2.73

−1.42

0.000

0.000

0.000

 

4.06

m

2.71

−1.49

0.000

0.000

0.000

33 α-Glucose

3.54

dd

2.69

−1.68

0.000

0.000

0.000

 

5.23

d

2.98

−2.83

0.000

0.000

0.000

34 Glycine

3.57

s

1.89

−1.33

0.056

0.040

0.046

35 Glycerol

3.65

dd

2.27

−1.51

0.000

0.000

0.000

36 Dimethylglycine

3.71

s

2.90

−2.18

0.000

0.000

0.000

37 Lysine

3.77

m

2.52

1.18

0.000

0.000

0.000

38 Glycolate

3.93

s

1.12

−1.08

0.000

0.000

0.000

39 Serine

3.98

m

2.14

1.10

0.000

0.000

0.000

40 Uracil

5.8

d

2.16

4.89

0.000

0.000

0.000

 

7.54

d

2.11

2.33

0.000

0.000

0.000

41 Fumarate

6.53

s

1.23

1.20

0.001

0.007

0.002

42 4-hydroxyphenylactate

6.88

d

2.40

1.51

0.000

0.000

0.000

 

7.18

d

2.59

1.22

0.000

0.000

0.000

43 Tyrosine

6.9

d

2.40

1.53

0.000

0.000

0.000

 

7.2

d

2.59

1.22

0.000

0.000

0.031

44 Trytophan

7.29

m

1.36

−1.39

0.000

0.000

0.000

45 Phenyacetylglutamine

7.42

m

2.55

1.11

0.000

0.000

0.000

46 Adenine

8.12

m

1.26

1.21

0.002

0.000

0.004

47 Hypoxanthine

8.18

s

1.48

−1.08

0.001

0.001

0.003

 

8.21

s

1.48

−1.42

0.000

0.001

0.000

48 Formate

8.44

s

1.39

−1.04

0.009

0.009

0.015

  1. aMultiplicity: s singlet, d doublet, t triplet, q quartet, dd doublet of doublets, m multiplet, br broad; bVariable importance in the projection was obtained from OPLS-DA model with a threshold of 1.0. cFold change (FC) between gastric cancer patients and normal controls. Fold change with a positive value indicates a relatively higher concentration present in gastric cancer patients while a negative value means a relatively lower concentration as compared to the normal controls. d P-value obtained from Student’s t-test